HOMCOS(prot_sch_conbars.cgi):

		Contact Molecules for Homologous Proteins
[Full Bars]	[SiteTable]	Summary Bars[0.0 %]	[Back to Search Page]	[Back to HOMCOS]
[SupCon3D]	[help]	seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]	[show] [download] [help]

PID

QueryLength

Homolgous Sequence in PDB

UniProt Query

TITLE

1701617

1255

500

P59594(SPIKE_SARS)

RecName: Full=Spike glycoprotein ; Short=S glycoprotein ;AltName: Full=E2 ;AltName: Full=Peplomer protein ;Contains: RecName: Full=Spike protein S1 ;Contains: RecName: Full=Spike protein S2 ;Contains: RecName: Full=Spike protein S2' ;Flags: Precursor;

QUERYSEQ

MFIFLLFLTLTSGSDLDRCTTFDDVQAPNYTQHTSSMRGVYYPDEIFRSDTLYLTQDLFLPFYSNVTGFHTINHTFGNPVIPFKDGIYFAATEKSNVVRGWVFGSTMNNKSQSVIIINNSTNVVIRACNFELCDNPFFAVSKPMGTQTHT
MIFDNAFNCTFEYISDAFSLDVSEKSGNFKHLREFVFKNKDGFLYVYKGYQPIDVVRDLPSGFNTLKPIFKLPLGINITNFRAILTAFSPAQDIWGTSAAAYFVGYLKPTTFMLKYDENGTITDAVDCSQNPLAELKCSVKSFEIDKGIY
QTSNFRVVPSGDVVRFPNITNLCPFGEVFNATKFPSVYAWERKKISNCVADYSVLYNSTFFSTFKCYGVSATKLNDLCFSNVYADSFVVKGDDVRQIAPGQTGVIADYNYKLPDDFMGCVLAWNTRNIDATSTGNYNYKYRYLRHGKLRP
FERDISNVPFSPDGKPCTPPALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFELLNAPATVCGPKLSTDLIKNQCVNFNFNGLTGTGVLTPSSKRFQPFQQFGRDVSDFTDSVRDPKTSEILDISPCSFGGVSVITPGTNASSEVAVLYQD
VNCTDVSTAIHADQLTPAWRIYSTGNNVFQTQAGCLIGAEHVDTSYECDIPIGAGICASYHTVSLLRSTSQKSIVAYTMSLGADSSIAYSNNTIAIPTNFSISITTEVMPVSMAKTSVDCNMYICGDSTECANLLLQYGSFCTQLNRALS
GIAAEQDRNTREVFAQVKQMYKTPTLKYFGGFNFSQILPDPLKPTKRSFIEDLLFNKVTLADAGFMKQYGECLGDINARDLICAQKFNGLTVLPPLLTDDMIAAYTAALVSGTATAGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYE
NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQAAPHGVVFLHVTYV
PSQERNFTTAPAICHEGKAYFPREGVFVFNGTSWFITQRNFFSPQIITTDNTFVSGNCDVVIGIINNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVWL
GFIAGLIAIVMVTILLCCMTSCCSCLKGACSCGSCCKFDEDDSEPVLKGVKLHYT

[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

UniProt Feature Tables [P59594(SPIKE_SARS)]

1255
	region	name	description
	1-13	SIGNAL
	14-1255	CHAIN	/note="Spike glycoprotein" /id="PRO_0000037208"
	14-667	CHAIN	/note="Spike protein S1" /id="PRO_0000037209"
	668-1255	CHAIN	/note="Spike protein S2" /id="PRO_0000037210"
	798-1255	CHAIN	/note="Spike protein S2'" /id="PRO_0000444082"
	14-1195	TOPO_DOM	/note="Extracellular"
	1196-1216	TRANSMEM	/note="Helical"
	1217-1255	TOPO_DOM	/note="Cytoplasmic"
	14-290	DOMAIN	/note="BetaCoV S1-NTD"
	321-513	DOMAIN	/note="BetaCoV S1-CTD"
	306-527	REGION	/note="Receptor-binding domain (RBD)"
	424-494	REGION	/note="Receptor-binding motif; binding to human ACE2"
	798-819	REGION	/note="Fusion peptide 1" ECO:0000305\|PubMed:29056462"
	817-837	REGION	/note="Fusion peptide 2" ECO:0000305\|PubMed:29056462"
	902-952	REGION	/note="Heptad repeat 1"
	1145-1184	REGION	/note="Heptad repeat 2"
	931-975	COILED
	1157-1185	COILED
	1-1255	DISORDER	predicted by DISOPRED

MONOMER

1255

pdb_id a¹ identity[%]² description

7sg4 C 99.8 SPIKE_SARS Spike glycoprotein

7akj G 99.6 Q5DIC5_CVHSA Spike glycoprotein

7upw C 77.2 SPIKE_SARS2 Spike glycoprotein

1.a¹:asym_id for the homologue. 2.identity[%]²:sequence identity between the query and the homologue.

HETERO

1255 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7sg4[1] D DH1047 Heavy chain[232 aa] A 100.0
/99.8 18
/18 SPIKE_SARS Spike glycoprotein

7sg4[1] E DH1047 light chain[220 aa] A 100.0
/99.8 14
/14 SPIKE_SARS Spike glycoprotein

7nd9[1] E COVOX-253H55L Fab light chain[214 aa] B 0.0
/78.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7qti[1] E P5C3 Light Chain[215 aa] K 50.0
/75.7 6
/6 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein

8kdm[2] E PW5-5 light chain[213 aa] A 100.0
/99.7 4
/4 SPIKE_SARS Spike glycoprotein

8kdm[1] C PW5-5 light chain[213 aa] G 100.0
/99.7 1
/1 SPIKE_SARS Spike glycoprotein

8kdm[2] D PW5-5 heavy chain[218 aa] A 100.0
/99.7 12
/12 SPIKE_SARS Spike glycoprotein

8kdm[1] B PW5-5 heavy chain[218 aa] G 100.0
/99.7 3
/3 SPIKE_SARS Spike glycoprotein

8kds[3] E PW5-535 heavy chain[217 aa] G 100.0
/99.7 11
/11 SPIKE_SARS Spike glycoprotein

8kds[3] F PW5-535 light chain[212 aa] G 100.0
/99.7 12
/12 SPIKE_SARS Spike glycoprotein

6nb7[3] I S230 light chain[110 aa] A 100.0
/99.7 3
/3 SPIKE_CVHSA Spike glycoprotein

8gnh[1] D Heavy chain of BD-218[121 aa] B 30.0
/78.2 10
/10 SPIKE_SARS2 Spike glycoprotein

8gnh[1] E Light chain of BD-218[106 aa] B 20.0
/78.2 5
/5 SPIKE_SARS2 Spike glycoprotein

8r1d[3] C SD1-3 Fab Heavy Chain[121 aa] E 62.5
/77.7 8
/8 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8r1d[3] D SD1-3 Fab Light Chain[106 aa] E 62.5
/77.7 8
/8 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8r1d[2] I SD1-3 Fab Light Chain[106 aa] E 100.0
/77.7 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7ls9[3] B 1-57 Fab heavy chain[129 aa] A 42.9
/77.4 14
/14 SPIKE_SARS2 Spike glycoprotein

8r1c[3] B SD1-2 fab heavy chain[124 aa] A 55.6
/77.4 9
/9 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8r1c[3] C SD1-2 fab light chain[109 aa] A 42.9
/77.4 7
/7 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7dzy[3] I Fab light chain of enhancing antibody 2490[213 aa].. A 33.3
/76.1 3
/3 SPIKE_SARS2 Spike glycoprotein

7qti[2] H P2G3 Light Chain[214 aa] I 0.0
/75.7 1
/1 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein

7upw[3] E SP1-77 Fab light chain[212 aa] A 0.0
/77.2 2
/2 SPIKE_SARS2 Spike glycoprotein

7upw[3] D SP1-77 Fab heavy chain[225 aa] A 69.2
/77.2 13
/13 SPIKE_SARS2 Spike glycoprotein

8gjm[1] D Heavy chain of 17B10 fab[119 aa] A 25.0
/76.9 8
/8 SPIKE_SARS2 Spike glycoprotein

8gjm[1] E Light chain of 17B10 fab[106 aa] A 25.0
/76.9 4
/4 SPIKE_SARS2 Spike glycoprotein

7lqv[2] D 4-8 Heavy Chain[125 aa] A 10.0
/76.7 10
/15 SPIKE_SARS2 Spike glycoprotein

7lqv[2] E 4-8 Light chain[105 aa] A 0.0
/76.7 4
/5 SPIKE_SARS2 Spike glycoprotein

7mxp[3] F LP5 Fab Heavy Chain[119 aa] A 12.5
/77.0 8
/15 SPIKE_SARS2 Spike glycoprotein

7mxp[3] G LP5 Fab Light Chain[107 aa] A 0.0
/77.0 6
/11 SPIKE_SARS2 Spike glycoprotein

7vq0[3] D Neutralizing nanobody P86[116 aa] A 44.4
/77.0 18
/19 SPIKE_SARS2 Spike glycoprotein

7vq0[1] D Neutralizing nanobody P86[116 aa] B 60.0
/77.4 5
/5 SPIKE_SARS2 Spike glycoprotein

7vq0[1] E Neutralizing nanobody P86[116 aa] C 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7l2e[3] D 4-18 heavy chain[122 aa] A 20.0
/76.7 10
/18 SPIKE_SARS2 Spike glycoprotein

7l2e[3] E 4-18 light chain[109 aa] A 0.0
/76.7 4
/8 SPIKE_SARS2 Spike glycoprotein

7rw2[3] D 5-7 heavy chain[134 aa] A 59.1
/76.6 22
/22 SPIKE_SARS2 Spike glycoprotein

7rw2[3] E 5-7 light chain[106 aa] A 0.0
/76.6 2
/2 SPIKE_SARS2 Spike glycoprotein

7x08[3] D heavy chain of 2G1[214 aa] A 28.6
/76.5 7
/7 SPIKE_SARS2 Spike glycoprotein

7x08[3] H heavy chain of 2G1[214 aa] A 100.0
/76.5 2
/2 SPIKE_SARS2 Spike glycoprotein

7x08[3] E light chain of 2G1[211 aa] A 20.0
/76.5 5
/5 SPIKE_SARS2 Spike glycoprotein

8cxn[3] D pan-sarbecovirus nanobody 2-57[126 aa] A 93.8
/76.4 16
/16 SPIKE_SARS2 Spike glycoprotein

8cxn[1] F pan-sarbecovirus nanobody 2-57[126 aa] C 100.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

8cy9[3] D pan-sarbecovirus nanobody 1-23[121 aa] A 88.9
/76.4 18
/18 SPIKE_SARS2 Spike glycoprotein

8cya[3] F pan-sarbecovirus nanobody 2-67[127 aa] A 30.0
/76.4 10
/11 SPIKE_SARS2 Spike glycoprotein

7l2d[1] B 1-87 heavy chain[127 aa] A 11.1
/76.4 9
/16 SPIKE_SARS2 Spike glycoprotein

7l2d[1] C 1-87 light chain[109 aa] A 33.3
/76.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7dzx[1] D Fab Heavy chain of enhancing antibody[227 aa] C 0.0
/76.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7dzy[3] H Fab Heavy chain of enhancing antibody 2490[225 aa].. A 0.0
/76.1 2
/5 SPIKE_SARS2 Spike glycoprotein

6acg[4] D ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] C 100.0
/100.0 16
/16 SPIKE_CVHSA Spike glycoprotein

6cs2[1] D ACE2_HUMAN Angiotensin-converting enzyme 2[544 aa] B 100.0
/99.7 19
/19 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

7we7[3] A Heavy chain of Fab 282[118 aa] C 50.0
/75.9 10
/10 SPIKE_SARS2 Spike glycoprotein

7we7[1] A Heavy chain of Fab 282[118 aa] E 100.0
/75.9 3
/3 SPIKE_SARS2 Spike glycoprotein

7we7[3] B The light chain of Fab 282[111 aa] C 0.0
/75.9 2
/2 SPIKE_SARS2 Spike glycoprotein

7we8[1] D Heavy chain of Fab 265[119 aa] A 41.7
/75.9 12
/12 SPIKE_SARS2 Spike glycoprotein

7we8[1] E Light chain of Fab 265[109 aa] A 25.0
/75.9 4
/4 SPIKE_SARS2 Spike glycoprotein

7we8[1] E Light chain of Fab 265[109 aa] B 0.0
/75.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7we9[1] D The heavy chain of Fab XGv289[120 aa] A 0.0
/75.9 3
/3 SPIKE_SARS2 Spike glycoprotein

7we9[3] E The heavy chain of Fab XGv289[120 aa] A 16.7
/75.9 6
/6 SPIKE_SARS2 Spike glycoprotein

7we9[3] G The light chain of Fab XGv289[111 aa] A 50.0
/75.9 6
/6 SPIKE_SARS2 Spike glycoprotein

7we9[1] I The light chain of Fab XGv289[111 aa] C 25.0
/75.9 4
/4 SPIKE_SARS2 Spike glycoprotein

7wec[2] A The heavy chain of Fab XGv347[123 aa] G 0.0
/75.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7wec[3] B The heavy chain of Fab XGv347[123 aa] G 30.0
/75.9 10
/10 SPIKE_SARS2 Spike glycoprotein

7wec[3] F The light chain of Fab XGv347[107 aa] G 50.0
/75.9 2
/2 SPIKE_SARS2 Spike glycoprotein

7n9t[3] E Nanobody Nb17[119 aa] A 66.7
/75.8 9
/9 SPIKE_SARS2 Spike glycoprotein

7n9t[3] F Nanobody Nb17[119 aa] A 0.0
/75.8 6
/6 SPIKE_SARS2 Spike glycoprotein

7nd9[1] D COVOX-253H55L Fab heavy chain[219 aa] B 15.4
/78.4 13
/13 SPIKE_SARS2 Spike glycoprotein

7qti[1] F P5C3 Heavy Chain[221 aa] K 42.9
/75.7 7
/8 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein

7qti[3] G P2G3 Heavy Chain[228 aa] I 41.7
/75.7 12
/12 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein

8dzh[1] D antibody MB.02 heavy chain[118 aa] B 42.9
/75.7 7
/7 SPIKE_SARS2 Spike glycoprotein

7wtf[3] A Heavy chain of XGv051[120 aa] C 41.7
/75.6 12
/12 SPIKE_SARS2 Spike glycoprotein

7wtf[3] B Light chain of XGv051[104 aa] C 16.7
/75.6 6
/6 SPIKE_SARS2 Spike glycoprotein

7wti[3] D Heavy chain of XGv264[118 aa] A 20.0
/75.6 10
/10 SPIKE_SARS2 Spike glycoprotein

7wti[3] G Light chain of XGv264[111 aa] A 40.0
/75.6 5
/5 SPIKE_SARS2 Spike glycoprotein

7wti[1] G Light chain of XGv264[111 aa] B 50.0
/75.6 4
/4 SPIKE_SARS2 Spike glycoprotein

7wtk[3] B Heavy chain of XGv286[118 aa] A 20.0
/75.6 5
/5 SPIKE_SARS2 Spike glycoprotein

7wtk[1] F Heavy chain of XGv286[118 aa] A 85.7
/75.6 7
/7 SPIKE_SARS2 Spike glycoprotein

7wtk[3] C Light chain of XGv286[109 aa] A 42.9
/75.6 7
/7 SPIKE_SARS2 Spike glycoprotein

7wtk[1] H Light chain of XGv286[109 aa] E 40.0
/75.6 5
/5 SPIKE_SARS2 Spike glycoprotein

8oyt[3] F H6 nanobody[126 aa] A 55.6
/75.7 9
/9 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8oyu[2] E H6 nanobody[126 aa] A 66.7
/75.5 6
/6 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7ls9[3] C 1-57 Fab light chain[108 aa] A 16.7
/77.4 6
/6 SPIKE_SARS2 Spike glycoprotein

7tcc[3] G Light chain of antibody B1-182.1[108 aa] A 100.0
/75.5 2
/2 SPIKE_SARS2 Spike glycoprotein

7tca[2] F Heavy chain of antibody A19-46.1[231 aa] B 57.1
/75.5 7
/7 SPIKE_SARS2 Spike glycoprotein

7tca[2] G Light chain of antibody A19-46.1[216 aa] B 45.5
/75.5 11
/11 SPIKE_SARS2 Spike glycoprotein

7tcc[3] D Heavy chain of antibody A19-46.1[126 aa] A 60.0
/75.5 10
/10 SPIKE_SARS2 Spike glycoprotein

7tcc[3] E Light chain of antibody A19-46.1[110 aa] A 46.2
/75.5 13
/13 SPIKE_SARS2 Spike glycoprotein

7tcc[3] F heavy chain of antibody B1-182.1[122 aa] A 18.2
/75.5 11
/11 SPIKE_SARS2 Spike glycoprotein

8xbf[1] D O5C2, heavy chain[114 aa] A 53.8
/75.1 13
/13 SPIKE_SARS2 Spike glycoprotein

8xbf[1] F O5C2, heavy chain[114 aa] B 40.0
/75.1 5
/5 SPIKE_SARS2 Spike glycoprotein

8xbf[1] E O5C2, light chain[109 aa] A 28.6
/75.1 7
/7 SPIKE_SARS2 Spike glycoprotein

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

COMPOUND

1255 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

6zoz[4] CA BLA
BILIVERDINE IX ALPHA[43 atoms] A 75.0
/77.7 8
/8 SPIKE_SARS2 Spike glycoprotein

8h0y[5] U BLA
BILIVERDINE IX ALPHA[43 atoms] A 100.0
/99.8 12
/12 SPIKE_SARS Spike glycoprotein

7e7b[3] XA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. A 72.7
/76.8 11
/11 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain

7e7b[3] YA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. A 66.7
/76.8 3
/3 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain

7wgv[2] EA BLR
3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrr.. A 54.5
/76.7 11
/11 SPIKE_SARS2 Spike glycoprotein

7qur[3] BA GE9
2,3,5-tris(iodanyl)benzamide[12 atoms] A 60.0
/76.6 5
/5 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7qur[3] CA SIA
N-acetyl-alpha-neuraminic acid[21 atoms] A 0.0
/76.6 6
/8 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

5x58[863] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 4
/4 Spike glycoprotein

5x58[87] D NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 Spike glycoprotein

5x58[3] E NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 2
/2 Spike glycoprotein

5x58[3] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 2
/2 Spike glycoprotein

5x58[358] G NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 Spike glycoprotein

5x58[3] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 Spike glycoprotein

5x58[9] I NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 6
/6 Spike glycoprotein

5x58[8] J NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 2
/2 Spike glycoprotein

5x58[5] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 Spike glycoprotein

5x58[354] L NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 3
/3 Spike glycoprotein

5x58[3] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 Spike glycoprotein

6nb7[2] WA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[6] XA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[2] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.7 3
/3 SPIKE_CVHSA Spike glycoprotein

6xm0[25] DA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 66.7
/78.6 3
/3 SPIKE_SARS2 Spike glycoprotein

6xm0[15] EA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 50.0
/78.6 2
/2 SPIKE_SARS2 Spike glycoprotein

6xm0[12] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/78.6 1
/1 SPIKE_SARS2 Spike glycoprotein

6xm0[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 0.0
/78.6 1
/1 SPIKE_SARS2 Spike glycoprotein

6xm0[39] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/78.6 2
/2 SPIKE_SARS2 Spike glycoprotein

6xm4[15] DA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 0.0
/78.5 1
/1 SPIKE_SARS2 Spike glycoprotein

6zge[3] AB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

6zge[3] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

6zoz[6] BA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/77.7 1
/3 SPIKE_SARS2 Spike glycoprotein

6zoz[39] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 50.0
/77.7 2
/2 SPIKE_SARS2 Spike glycoprotein

6zoz[3] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/77.7 1
/1 SPIKE_SARS2 Spike glycoprotein

6zoz[11] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 50.0
/77.7 2
/2 SPIKE_SARS2 Spike glycoprotein

6zoz[20] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/77.7 1
/1 SPIKE_SARS2 Spike glycoprotein

6zoz[11] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/77.7 1
/1 SPIKE_SARS2 Spike glycoprotein

6zoz[6] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 75.0
/77.7 4
/4 SPIKE_SARS2 Spike glycoprotein

6zoz[6] Y NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/77.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7cn4[128] O NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 50.0
/76.5 2
/2 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn4[86] P NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.5 2
/2 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn4[4] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.5 1
/1 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn4[106] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.5 3
/3 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn8[3] LB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.8 1
/1 Glycoprotein

7krs[44] TA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/77.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7lqv[2] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7lqv[1] K NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 25.0
/76.7 4
/4 SPIKE_SARS2 Spike glycoprotein

7lqv[2] L NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7lqv[2] P NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

7lqv[2] Q NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7lqv[2] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 2
/2 SPIKE_SARS2 Spike glycoprotein

7lqv[1] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/76.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7ls9[8] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/77.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7n1y[1] PA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7ru2[9] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.1 3
/3 SPIKE_SARS2 Spike glycoprotein

7ru2[6] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbk[4] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/77.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbo[1] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/77.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7sg4[3] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 4
/4 SPIKE_SARS Spike glycoprotein

7sg4[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 SPIKE_SARS Spike glycoprotein

7sg4[3] L NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 3
/3 SPIKE_SARS Spike glycoprotein

7sg4[3] M NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 SPIKE_SARS Spike glycoprotein

7sg4[1] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/99.8 5
/5 SPIKE_SARS Spike glycoprotein

7tb4[7] SA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 0.0
/75.4 1
/1 A0A8A4XEV3_SARS2 Surface glycoprotein

7tb4[1] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 0.0
/75.5 1
/1 A0A8A4XEV3_SARS2 Surface glycoprotein

7tca[1] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/75.5 1
/1 SPIKE_SARS2 Spike glycoprotein

7tpl[1] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/79.0 2
/2 SPIKE_SARS2 Spike glycoprotein

7we7[2] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. E 100.0
/75.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgb[1] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 83.3
/76.0 6
/6 SPIKE_SARS2 Spike glycoprotein

7wgv[3] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[3] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[3] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[6] W NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 66.7
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

7wtf[6] DA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/75.6 2
/2 SPIKE_SARS2 Spike glycoprotein

7wtf[2] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/75.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7wtk[1] FA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. D 0.0
/75.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7wtk[1] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. D 100.0
/75.6 6
/6 SPIKE_SARS2 Spike glycoprotein

7ybh[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.5 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[3] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/76.5 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 0.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] WA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/76.2 1
/1 SPIKE_SARS2 Spike glycoprotein

7zh1[9] FA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.9 2
/2 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin

7zh1[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.9 1
/1 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/83.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/83.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] T NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/83.2 4
/4 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/83.2 3
/3 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] DB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/88.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] EA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/88.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/88.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[2] V NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/88.2 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8cya[1] BB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 0.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

8d55[3] UA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 100.0
/76.1 1
/1 SPIKE_SARS2 Spike glycoprotein

8gnh[1] P NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/78.2 1
/1 SPIKE_SARS2 Spike glycoprotein

8h0y[13] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 2
/2 SPIKE_SARS Spike glycoprotein

8h0y[9] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 2
/2 SPIKE_SARS Spike glycoprotein

8h0y[9] O NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 SPIKE_SARS Spike glycoprotein

8h0y[14] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 4
/4 SPIKE_SARS Spike glycoprotein

8h0y[8] UA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 SPIKE_SARS Spike glycoprotein

8h0y[6] W NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/99.8 1
/1 SPIKE_SARS Spike glycoprotein

8h16[1] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/100.0 1
/1 SPIKE_SARS Spike glycoprotein

8hxj[1] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 25.0
/76.9 4
/4 SPIKE_SARS2 Spike glycoprotein

8oyt[2] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 0.0
/75.7 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8oyt[1] T NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. B 100.0
/75.7 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8tc0[3] WA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/92.5 1
/1 U5WI05_SARS Spike glycoprotein

8xbf[3] J NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 100.0
/75.1 1
/1 SPIKE_SARS2 Spike glycoprotein

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

OTHERPOLY

1255 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/76.6 3
/3 SPIKE_SARS2 Spike glycoprotein

7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. C 66.7
/76.5 3
/3 SPIKE_SARS2 Spike glycoprotein

7krs[55] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/77.1 3
/3 SPIKE_SARS2 Spike glycoprotein

7nd9[1] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. B 0.0
/78.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7upw[3] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/77.2 4
/4 SPIKE_SARS2 Spike glycoprotein

8cya[2] X 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

8tc0[3] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 75.0
/92.5 4
/4 U5WI05_SARS Spike glycoprotein

8tc0[3] DA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/92.5 1
/1 U5WI05_SARS Spike glycoprotein

8tc0[3] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/92.5 3
/3 U5WI05_SARS Spike glycoprotein

8tc0[3] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/92.5 2
/2 U5WI05_SARS Spike glycoprotein

8tc0[3] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/92.5 3
/3 U5WI05_SARS Spike glycoprotein

8tc0[3] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 50.0
/92.5 2
/2 U5WI05_SARS Spike glycoprotein

7jjj[2] HC beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.5 3
/3 SPIKE_SARS2 Spike glycoprotein

7jjj[2] TA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 66.7
/76.5 3
/3 SPIKE_SARS2 Spike glycoprotein

8tc0[3] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 6
/6 U5WI05_SARS Spike glycoprotein

8tc0[3] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 2
/2 U5WI05_SARS Spike glycoprotein

8tc0[3] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 5
/5 U5WI05_SARS Spike glycoprotein

8tc0[3] X beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 1
/1 U5WI05_SARS Spike glycoprotein

6crw[5] D beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[3] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[5] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 5
/5 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[8] W beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7 5
/5 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crx[3] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs1[1] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7 5
/5 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[1] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[1] Q beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[22] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6nb7[3] AA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[3] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[4] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[2] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[3] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[3] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 3
/3 SPIKE_CVHSA Spike glycoprotein

6nb7[3] O beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[2] Q beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[6] EA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7 3
/3 SPIKE_CVHSA Spike glycoprotein

6nb7[7] JA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[1] TA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

7l2d[2] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 66.7
/76.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7l2d[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 40.0
/76.4 5
/5 SPIKE_SARS2 Spike glycoprotein

7ls9[7] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 33.3
/77.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7qo7[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 33.3
/75.9 3
/3 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qo7[4] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9 1
/1 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qo7[21] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9 1
/1 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qo7[6] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9 2
/2 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qo7[2] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9 1
/1 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qo7[2] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 0.0
/75.8 1
/1 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7wtf[6] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 75.0
/75.6 4
/4 SPIKE_SARS2 Spike glycoprotein

7wtf[5] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/75.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/76.5 2
/2 SPIKE_SARS2 Spike glycoprotein

7ybh[3] H beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/76.5 3
/3 SPIKE_SARS2 Spike glycoprotein

7ybh[2] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 75.0
/76.4 4
/4 SPIKE_SARS2 Spike glycoprotein

7ybh[1] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.2 2
/2 SPIKE_SARS2 Spike glycoprotein

7ybh[4] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 25.0
/76.2 4
/4 SPIKE_SARS2 Spike glycoprotein

8cya[3] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/76.4 2
/2 SPIKE_SARS2 Spike glycoprotein

8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 0.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.4 2
/2 SPIKE_SARS2 Spike glycoprotein

8cya[1] T beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 66.7
/76.4 3
/3 SPIKE_SARS2 Spike glycoprotein

8tc0[3] BA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 3
/3 U5WI05_SARS Spike glycoprotein

8tc0[3] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 5
/5 U5WI05_SARS Spike glycoprotein

8tc0[3] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/92.5 2
/2 U5WI05_SARS Spike glycoprotein

8tc0[3] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 75.0
/92.5 4
/4 U5WI05_SARS Spike glycoprotein

8wlu[3] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/89.6 2
/2 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] H beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/89.6 2
/2 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/89.6 3
/3 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 75.0
/89.6 4
/4 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] MA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/89.6 1
/1 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] OA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/89.6 1
/1 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

6crw[5] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 4
/4 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[191] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 4
/4 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[59] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[9] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[4] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[9] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[4] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[4] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crx[2] BA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crx[4] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 5
/5 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crx[19] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crx[85] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs1[5] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6nb7[8] KA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[75] BA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[74] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

6nb7[1] KA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[1] PA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6xm0[26] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/78.6 2
/2 SPIKE_SARS2 Spike glycoprotein

6xm0[9] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/78.6 1
/1 SPIKE_SARS2 Spike glycoprotein

6xm4[4] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 50.0
/78.5 2
/2 SPIKE_SARS2 Spike glycoprotein

6xm4[4] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 50.0
/78.5 4
/4 SPIKE_SARS2 Spike glycoprotein

6zge[6] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7 2
/2 SPIKE_SARS2 Spike glycoprotein

6zge[3] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.7 1
/3 SPIKE_SARS2 Spike glycoprotein

6zge[133] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

6zge[4] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

6zge[3] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/76.7 4
/4 SPIKE_SARS2 Spike glycoprotein

6zge[31] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7 3
/3 SPIKE_SARS2 Spike glycoprotein

6zge[3] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

6zge[3] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7 2
/2 SPIKE_SARS2 Spike glycoprotein

6zge[3] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/76.7 6
/6 SPIKE_SARS2 Spike glycoprotein

6zoz[6] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.7 2
/2 SPIKE_SARS2 Spike glycoprotein

6zoz[87] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/77.7 3
/3 SPIKE_SARS2 Spike glycoprotein

7cn4[24] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.5 1
/1 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn8[3] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.8 1
/1 Glycoprotein

7cn8[38] X 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.8 1
/3 Glycoprotein

7cn8[107] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.8 2
/2 Glycoprotein

7cn8[1] BA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/76.8 1
/1 Glycoprotein

7e7b[42] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/76.8 4
/4 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain

7jjj[4] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.6 3
/3 SPIKE_SARS2 Spike glycoprotein

7jjj[7] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.6 4
/4 SPIKE_SARS2 Spike glycoprotein

7jjj[2] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/76.5 1
/1 SPIKE_SARS2 Spike glycoprotein

7krs[4] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/77.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7n1q[22] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.1 3
/3 SPIKE_SARS2 Spike glycoprotein

7n1q[14] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 50.0
/77.1 2
/2 SPIKE_SARS2 Spike glycoprotein

7n1v[2] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7n1v[6] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 0.0
/76.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7tb4[9] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/75.4 1
/1 A0A8A4XEV3_SARS2 Surface glycoprotein

7vq0[1] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.0 1
/1 SPIKE_SARS2 Spike glycoprotein

7we7[2] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/75.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7we7[1] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. D 100.0
/75.9 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[6] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7wgv[3] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 80.0
/76.7 5
/5 SPIKE_SARS2 Spike glycoprotein

7wtf[1] U 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/75.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[2] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.5 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 66.7
/76.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7ybh[2] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7ybh[1] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7ybh[1] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 0.0
/76.2 1
/1 SPIKE_SARS2 Spike glycoprotein

8aja[3] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/83.2 4
/4 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/83.2 4
/4 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 50.0
/83.2 6
/6 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/88.2 4
/4 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/88.2 3
/3 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8h0z[4] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8 4
/4 SPIKE_SARS Spike glycoprotein

8oyt[3] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 80.0
/75.7 5
/5 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8oyt[1] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 0.0
/75.7 1
/1 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8tc0[3] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 71.4
/92.5 7
/7 U5WI05_SARS Spike glycoprotein

8wlu[3] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/89.6 2
/2 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/89.6 2
/2 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] O 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/89.6 4
/4 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/89.6 1
/1 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] YA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/89.6 3
/3 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

6crw[1] U alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. C 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[1] U alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6nb7[1] FA alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7 4
/4 SPIKE_CVHSA Spike glycoprotein

6nb7[1] GA alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

7tf8[1] K alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/78.2 2
/2 SPIKE_SARS2 Spike glycoprotein

6cs1[1] G alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 4
/4 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs1[1] H alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 4
/4 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs1[1] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs1[1] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. C 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6nb7[1] P alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 1
/1 SPIKE_CVHSA Spike glycoprotein

6nb7[3] R alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 5
/5 SPIKE_CVHSA Spike glycoprotein

6nb7[1] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 4
/4 SPIKE_CVHSA Spike glycoprotein

6nb7[1] U alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7 2
/2 SPIKE_CVHSA Spike glycoprotein

7tf8[1] I alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/78.2 4
/4 SPIKE_SARS2 Spike glycoprotein

7tf8[1] L alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 25.0
/78.2 4
/4 SPIKE_SARS2 Spike glycoprotein

7tf8[1] L alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 50.0
/78.2 4
/4 SPIKE_SARS2 Spike glycoprotein

7tf8[2] N alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 75.0
/78.2 4
/4 SPIKE_SARS2 Spike glycoprotein

7krs[52] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.1 4
/4 SPIKE_SARS2 Spike glycoprotein

7n1q[22] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbk[21] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.4 6
/6 SPIKE_SARS2 Spike glycoprotein

7sbk[9] E alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 66.7
/77.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7sbk[21] F alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbk[3] H alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.4 4
/4 SPIKE_SARS2 Spike glycoprotein

7sbk[21] I alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4 3
/3 SPIKE_SARS2 Spike glycoprotein

7sbk[6] L alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbk[6] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4 4
/4 SPIKE_SARS2 Spike glycoprotein

7sbk[4] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbk[15] P alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbk[8] X alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbp[6] I alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.6 4
/4 SPIKE_SARS2 Spike glycoprotein

7sbp[20] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbp[8] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.6 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbp[6] O alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.6 2
/2 SPIKE_SARS2 Spike glycoprotein

7sbp[6] Z alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbp[2] EA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 0.0
/77.6 1
/1 SPIKE_SARS2 Spike glycoprotein

7sbt[3] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/76.3 2
/7 SPIKE_SARS2 Spike glycoprotein

7tnw[6] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/76.3 2
/2 SPIKE_SARS2 Spike glycoprotein

7tnw[12] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/76.3 4
/4 SPIKE_SARS2 Spike glycoprotein

8d55[6] AA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/76.1 1
/1 SPIKE_SARS2 Spike glycoprotein

7qur[6] G alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 50.0
/76.6 2
/2 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7qur[6] K alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 66.7
/76.6 3
/3 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

6crw[5] E alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[3] F alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7 3
/3 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[5] T alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7 1
/1 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[6] O alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/99.7 4
/4 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6crw[1] R alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. C 100.0
/99.7 5
/5 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[1] P alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/99.7 2
/2 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6nb7[2] T alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7 4
/4 SPIKE_CVHSA Spike glycoprotein

7qo7[1] D alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 60.0
/75.9 5
/5 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..

7qti[1] X alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. K 66.7
/75.7 3
/3 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein

7tf8[1] H alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 75.0
/78.2 4
/4 SPIKE_SARS2 Spike glycoprotein

7tf8[1] O alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/78.2 2
/2 SPIKE_SARS2 Spike glycoprotein

7ybh[1] J alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 66.7
/76.5 3
/3 SPIKE_SARS2 Spike glycoprotein

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

HOMO

1255 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

8h16[1] B SPIKE_SARS Spike glycoprotein[805 aa] A 100.0
/100.0 60
/60 SPIKE_SARS Spike glycoprotein

8h16[1] B SPIKE_SARS Spike glycoprotein[805 aa] C 100.0
/100.0 77
/77 SPIKE_SARS Spike glycoprotein

6cs2[1] A SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[891 aa] B 100.0
/99.7 64
/64 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

6cs2[1] C SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[893 aa] B 98.6
/99.7 72
/72 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin

5x58[28] B Spike glycoprotein[1053 aa] A 100.0
/99.8 110
/110 Spike glycoprotein

5x58[28] C Spike glycoprotein[1052 aa] A 100.0
/99.8 93
/93 Spike glycoprotein

5xlr[24] B SPIKE_CVHSA Spike glycoprotein[1022 aa] A 100.0
/100.0 69
/69 SPIKE_CVHSA Spike glycoprotein

5xlr[24] C SPIKE_CVHSA Spike glycoprotein[1022 aa] A 100.0
/100.0 77
/77 SPIKE_CVHSA Spike glycoprotein

6nb7[3] B SPIKE_CVHSA Spike glycoprotein[1032 aa] A 100.0
/99.7 52
/52 SPIKE_CVHSA Spike glycoprotein

6nb7[3] C SPIKE_CVHSA Spike glycoprotein[1048 aa] A 100.0
/99.7 47
/47 SPIKE_CVHSA Spike glycoprotein

7zh1[3] B SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[1020 aa] A 100.0
/99.9 95
/95 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin

7zh1[3] C SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[1020 aa] A 100.0
/99.9 104
/104 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin

8tc0[3] B U5WI05_SARS Spike glycoprotein[1091 aa] A 98.1
/92.5 105
/105 U5WI05_SARS Spike glycoprotein

8tc0[3] C U5WI05_SARS Spike glycoprotein[1091 aa] A 100.0
/92.5 115
/115 U5WI05_SARS Spike glycoprotein

8wlu[3] B U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin[1106 aa] A 98.0
/89.6 100
/100 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8wlu[3] C U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin[1106 aa] A 93.4
/89.6 106
/106 U5WLK5_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin

8ajl[3] B SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1109 aa] A 95.1
/88.2 102
/102 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8ajl[3] C SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1109 aa] A 98.2
/88.2 113
/113 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] B SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1090 aa] A 90.1
/83.2 121
/121 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

8aja[3] C SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1090 aa] A 93.3
/83.2 104
/104 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7tpl[1] A SPIKE_SARS2 Spike glycoprotein[423 aa] B 93.3
/79.0 45
/45 SPIKE_SARS2 Spike glycoprotein

7cn8[3] B Glycoprotein[1125 aa] A 85.6
/76.8 111
/111 Glycoprotein

7cn8[3] C Glycoprotein[1125 aa] A 86.9
/76.8 107
/107 Glycoprotein

6xm0[36] A SPIKE_SARS2 Spike glycoprotein[1037 aa] B 89.4
/78.6 85
/85 SPIKE_SARS2 Spike glycoprotein

6xm0[36] C SPIKE_SARS2 Spike glycoprotein[1032 aa] B 85.7
/78.6 70
/70 SPIKE_SARS2 Spike glycoprotein

6zge[3] B SPIKE_SARS2 Spike glycoprotein[1098 aa] A 87.0
/76.7 108
/108 SPIKE_SARS2 Spike glycoprotein

6zge[3] C SPIKE_SARS2 Spike glycoprotein[1098 aa] A 88.3
/76.7 94
/94 SPIKE_SARS2 Spike glycoprotein

7cn4[173] B A0A6B9WHD3_CVHSA Spike glycoprotein[1120 aa] A 88.7
/76.5 106
/106 A0A6B9WHD3_CVHSA Spike glycoprotein

7cn4[174] C A0A6B9WHD3_CVHSA Spike glycoprotein[1120 aa] A 87.3
/76.5 110
/110 A0A6B9WHD3_CVHSA Spike glycoprotein

7jjj[2] F SPIKE_SARS2 Spike glycoprotein[1108 aa] A 77.8
/76.6 9
/9 SPIKE_SARS2 Spike glycoprotein

7jjj[2] D SPIKE_SARS2 Spike glycoprotein[1120 aa] C 14.3
/76.5 7
/12 SPIKE_SARS2 Spike glycoprotein

7lqv[2] B SPIKE_SARS2 Spike glycoprotein[1112 aa] A 84.9
/76.7 86
/86 SPIKE_SARS2 Spike glycoprotein

7lqv[2] C SPIKE_SARS2 Spike glycoprotein[1087 aa] A 90.2
/76.7 82
/82 SPIKE_SARS2 Spike glycoprotein

7n9t[3] B SPIKE_SARS2 Spike glycoprotein[1123 aa] A 85.5
/75.8 69
/69 SPIKE_SARS2 Spike glycoprotein

7n9t[4] C SPIKE_SARS2 Spike glycoprotein[1123 aa] A 86.5
/75.8 74
/74 SPIKE_SARS2 Spike glycoprotein

7vhl[1] B SPIKE_SARS2 Spike glycoprotein[1083 aa] A 90.0
/76.1 80
/80 SPIKE_SARS2 Spike glycoprotein

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

PRECIPITANT

1255 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7cn8[2] DB EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.8 3
/3 Glycoprotein

7cn8[2] TA EIC
LINOLEIC ACID[20 atoms] A 92.3
/76.8 13
/13 Glycoprotein

7qur[9] DA EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.6 3
/3 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7qur[9] TA EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.6 13
/13 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin

7wgv[3] AA EIC
LINOLEIC ACID[20 atoms] A 93.3
/76.7 15
/15 SPIKE_SARS2 Spike glycoprotein

7wgv[6] AB EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.7 1
/1 SPIKE_SARS2 Spike glycoprotein

7xu4[3] DA EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.3 4
/4 SPIKE_SARS2 Spike glycoprotein

7xu4[3] TA EIC
LINOLEIC ACID[20 atoms] A 100.0
/76.3 15
/15 SPIKE_SARS2 Spike glycoprotein

7zh1[3] G EIC
LINOLEIC ACID[20 atoms] A 100.0
/99.9 8
/8 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin

8h0y[9] D EIC
LINOLEIC ACID[20 atoms] A 100.0
/99.8 11
/11 SPIKE_SARS Spike glycoprotein

8h0y[11] MA EIC
LINOLEIC ACID[20 atoms] A 100.0
/99.8 3
/3 SPIKE_SARS Spike glycoprotein

8tc0[3] OA EIC
LINOLEIC ACID[20 atoms] A 100.0
/92.5 16
/16 U5WI05_SARS Spike glycoprotein

7e7b[3] VA ELA
9-OCTADECENOIC ACID[20 atoms] A 100.0
/76.8 14
/14 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain

7e7b[3] WA ELA
9-OCTADECENOIC ACID[20 atoms] A 100.0
/76.8 4
/4 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

MONOMER
1255
	pdb_id	a¹	identity[%]²	description
	7sg4	C	99.8	SPIKE_SARS Spike glycoprotein
	7akj	G	99.6	Q5DIC5_CVHSA Spike glycoprotein
	7upw	C	77.2	SPIKE_SARS2 Spike glycoprotein
	1.a¹:asym_id for the homologue. 2.identity[%]²:sequence identity between the query and the homologue.

Contact Molecules for Homologous Proteins

Summary Bars[0.0 %]

UniProt Feature Tables [P59594(SPIKE_SARS)]